The evaluation is part of the Phase 1/2/3 trial and will study a third dose of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, at 30 µg that […]
Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and demonstrated […]
Merck today announced a collaboration with Mammoth Biosciences Inc. for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test. Merck, a […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that preliminary, peer-reviewed data from the Phase 1 portion of their ongoing U.S. study […]
• Roche will obtain co-development and co-commercialisation rights for pralsetinib, an investigational, precision therapy in late-stage development for people with RET-altered non-small cell lung cancer, […]
President of the Commission, Ursula von der Leyen, participated yesterday in the Eastern Partnership leaders’ videoconference. Together with European Council President Charles Michel, High Representative/Vice-President […]
As of tomorrow and throughout the weekend, the Commission will host the pan-European #EUvsVirus Hackathon, under the patronage of Mariya Gabriel, Commissioner for Innovation, Research, […]
In a strong sign of solidarity, the European Parliament, with support from the EPP Group and other mainstream parties, supports a €3 billion plan to […]
On April 9, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Terumo BCT Inc. and Marker Therapeutics AG […]
https://elpais.com/elpais/2020/04/09/album/1586457256_299548.html#foto_gal_1 photos by www.elpais.com photo copyright John Minchillo AP
Copyright © 2021 | WordPress Theme by MH Themes
